Lv2
148 积分 2022-04-19 加入
The challenges and progress of CAR-T cell therapy in the treatment of solid tumors
1个月前
已完结
Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury
1个月前
已完结
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging
1个月前
已完结
A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer
1个月前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
1个月前
已完结
Claudin 18.2 as a novel therapeutic target
3个月前
已完结
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
3个月前
已完结
CAR therapies: development, design, and implementation
4个月前
已完结
The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs
5个月前
已完结
Scarless circular mRNA-based CAR-T cell therapy elicits superior anti-tumor efficacy
5个月前
已完结
皖公网安备34019202002308
